Market closed
Monopar Therapeutics Inc./$MNPR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Ticker
$MNPR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
10
Website
MNPR Metrics
BasicAdvanced
$211M
-
-$4.11
-
-
Price and volume
Market cap
$211M
52-week high
$47.83
52-week low
$27.05
Financial strength
Current ratio
11.475
Quick ratio
11.46
Management effectiveness
Return on assets (TTM)
-29.87%
Return on equity (TTM)
-51.42%
Valuation
Price to book
3.84
Price to tangible book (TTM)
3.84
Price to free cash flow (TTM)
-20.472
Growth
Earnings per share change (TTM)
35.32%
3-year earnings per share growth (CAGR)
4.06%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Monopar Therapeutics Inc. stock?
Monopar Therapeutics Inc. (MNPR) has a market cap of $211M as of April 05, 2025.
What is the P/E ratio for Monopar Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Monopar Therapeutics Inc. (MNPR) stock is 0 as of April 05, 2025.
Does Monopar Therapeutics Inc. stock pay dividends?
No, Monopar Therapeutics Inc. (MNPR) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Monopar Therapeutics Inc. dividend payment date?
Monopar Therapeutics Inc. (MNPR) stock does not pay dividends to its shareholders.
What is the beta indicator for Monopar Therapeutics Inc.?
Monopar Therapeutics Inc. (MNPR) does not currently have a Beta indicator.